Abstract:
Substantially pure salts of febuxostat of Formula (IA): wherein Y is Na+, K+, Li+, Mg2+, Ca2+, Zn2+, Ba2+, Sr2+, choline, epolamine and N+(R)4 and processes for preparation thereof are disclosed.
Abstract:
Substantially pure salts of febuxostat of Formula (IA): wherein Y is Na + , K + , Li + , Mg 2+ , Ca 2+ , Zn 2+ , Ba 2+ , Sr 2+ , choline, epolamine and N + (R) 4 and processes for preparation thereof are disclosed.
Abstract:
The present invention relates to cost efficient process for preparation of sucralose. The present invention relates to recovery of the reagents from feed mixture obtained in various steps of sucralose. Particularly, the present invention relates to recovery of trityl chloride, ß-picoline, triphenylphosphine oxide (TPPO) and methyl acetate.
Abstract:
The present invention relates to an improved process for the preparation of 1-bromo-3,5-dimethyl adamantane of formula (III), which is an useful intermediate for synthesis of 1-amino-3,5-dimethyl adamantane of formula (I) or pharmaceutically acceptable salt thereof.
Abstract:
The present invention relates to a selective process for preparation of Z-isomer of cefditoren of Formula I and pharmaceutically acceptable salts and esters thereof. cefditoren possesses a wide spectrum of antibacterial activity against Gram-positive and Gram-negative bacteria.
Abstract:
The present invention relates to an improved and industrially advantageous process for the preparation of pure 7-amino-3-alkoxymethyl-3-cephem-4-carboxylic acids, and salts thereof. In particular, the present invention relates to a process for the preparation of pure 7-amino-3-methoxymethyl-3-cephem-4-carboxylic acid (7-AMCA) and salts thereof.
Abstract:
The present invention relates to an improved and industrially advantageous process for the preparation of pure 7-amino-3-alkoxymethyl-3-cephem-4-carboxylic acids, and salts thereof. In particular, the present invention relates to a process for the preparation of pure 7-amino-3-methoxymethyl-3-cephem-4-carboxylic acid (7-AMCA) and salts thereof.
Abstract:
The invention discloses processes for the preparation of rivaroxaban and its pharmaceutically acceptable salts, solvates, and hydrates thereof. The invention also relates to novel intermediates for the preparation of rivaroxaban.